Reported covered position: Leg. Aide., Sen. Tom Harkin/Senate Agriculture Committee
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Telehealth Promotion Act of 2012
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: DLA PIPER LLP (US)
Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress).
Telehealth Promotion Act of 2012
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: DLA PIPER LLP (US)
Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress).
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MILLENNIUM LABORATORIES via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Medicare reimbursement and prescription drug abuse.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENSEOHEALTH via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Source: Senate LDA
| EMD SERONO, INC. |
| 9 |
| 2011–2013 |
| SCHILTZ FOODS, INC. | 8 | 2010–2012 |
| BLUE CROSS AND BLUE SHIELD ASSOCIATION | 6 | 2011–2012 |
| DES MOINES UNIVERSITY | 6 | 2010–2011 |
| LEMHI VENTURES | 5 | 2010–2011 |
| MEDCO HEALTH SOLUTIONS INC | 5 | 2011–2012 |
| CENSEOHEALTH | 4 | 2013–2014 |
| NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS | 4 | 2011 |
| AVALON HEALTH MANAGEMENT | 2 | 2012 |
| MILLENNIUM LABORATORIES | 2 | 2014 |
| PHAROS INNOVATIONS | 1 | 2010 |
Preventing Diabetes in Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Medicare Better Health Rewards Program Act of 2013
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare/Medicaid reimbursements; S. 1228, Medicare Better Health Records Program Act of 2013.
Medicare Better Health Rewards Program Act of 2013
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare/Medicaid reimbursements; S. 1228, Medicare Better Health Records Program Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Family Act of 2011 (S. 965 and H.R. 3522 in the 112th Congress).
Telehealth Promotion Act of 2012
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: DLA PIPER LLP (US)
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Telehealth Promotion Act of 2012
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: DLA PIPER LLP (US)
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Telehealth Promotion Act of 2012
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: DLA PIPER LLP (US)
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Telehealth Promotion Act of 2012
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: DLA PIPER LLP (US)
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
Counterfeit Drug Penalty Enhancement Act of 2012
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; H.R. 3668, The Counterfeit Drug Penalty Enhancement Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; H.R. 3668, The Counterfeit Drug Penalty Enhancement Act of 2012.
To extend the temporary suspension of duty on mixtures of indoxacarb and inert ingredients.
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.
To extend the temporary suspension of duty on mixtures of indoxacarb and inert ingredients.
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act; Issues related to supply chain safety.
To extend the temporary suspension of duty on mixtures of indoxacarb and inert ingredients.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
H.R. 5657, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act.
To extend the temporary suspension of duty on mixtures of indoxacarb and inert ingredients.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.
To extend the temporary suspension of duty on mixtures of indoxacarb and inert ingredients.
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
Medicare Advantage risk adjustment.
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Implementation of Public Law No. 111-148.
Filing targets: SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress).
Issues related to Medicare and Medicaid reimbursements.
Filing targets: SENATE
MILLENNIUM LABORATORIES via DLA PIPER LLP (US)
2014 · second_quarter · RR
Medicare coverage policies.
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Issues related to Medicare and Medicaid reimbursements.
Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress).
CENSEOHEALTH via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Medicare Advantage risk adjustment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Implementation of Public Law No. 111-148.
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: SENATE
CENSEOHEALTH via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Medicare Advantage risk adjustment.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
CENSEOHEALTH via DLA PIPER LLP (US)
2013 · fourth_quarter · RR
Medicare Advantage risk adjustment
AETNA, INC. via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; care coordination initiatives; health information technology.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Implementation of Public Law No. 111-148.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Issues related to Medicare/Medicaid reimbursements; S. 1228, Medicare Better Health Records Program Act of 2013.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Issues related to Medicare and Medicaid reimbursements.
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; care coordination initiatives; health information technology; wellness initiatives.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Issues related to Medicare/Medicaid reimbursements; S. 1228, Medicare Better Health Records Program Act of 2013.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Implementation of Public Law No. 111-148.
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Issues related to Medicare/Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Issues related to Medicare and Medicaid reimbursements.
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011. H.R. 8, American Taxpayer Relief Act of 2012. H.R. 1588/S. 740, Medicare Drug Savings Act of 2013. H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Implementation of Public Law No. 111-148.
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AETNA, INC. via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; care coordination initiatives; health information technology; wellness initiatives.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Issues related to Medicare/Medicaid reimbursements.
Family Act of 2011 (S. 965 and H.R. 3522 in the 112th Congress).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Issues related to Medicare and Medicaid reimbursements.
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Issues related to Medicare/Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Implementation of Public Law No. 111-148.
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AETNA, INC. via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; Care coordination initiatives; health information technology; Wellness initiatives.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Issues related to Medicare/Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Implementation of Public Law No. 111-148.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
Issues related to Medicare/Medicaid reimbursements.
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act; Issues related to supply chain safety.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; Care coordination initiatives; health information technology; Wellness initiatives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AVALON HEALTH MANAGEMENT via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Implementation of Public Law 111-148, provisions relating to skilled nursing facilities and reducing hospital re-admissions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; Care coordination initiatives; health information technology; Million Hearts Initiative and wellness initiatives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Implementation of Public Law No. 111-148.
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2012 · third_quarter · Q3
H.R. 5657, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2012 · third_quarter · Q3
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
Issues related to Medicare/Medicaid reimbursements.
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Issues related to Medicare/Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AVALON HEALTH MANAGEMENT via DLA PIPER LLP (US)
2012 · second_quarter · RR
Implementation of Public Law No. 111-148, provisions related to skilled nursing facilities and reducing hospital re-admissions.
AETNA, INC. via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; Care coordination initiatives; health information technology; Million Hearts Initiative and wellness initiatives.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
AETNA, INC. via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; Care coordination initiatives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via DLA PIPER LLP (US)
2012 · first_quarter · RR
Health care reform issues.
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Issues related to Medicare/Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; H.R. 3668, The Counterfeit Drug Penalty Enhancement Act of 2012.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Implementation of Public Law No. 111-148.
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2012 · second_quarter · Q2
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Issues related to Medicare and Medicaid drug rebates.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization.
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Reauthorization of the Prescription Drug User Fee Act.
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Issues related to Medicare and Medicaid drug rebates.
Prescription Drug User Fee Act; Reauthorization.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act.
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Implementation of Public Law No. 111-148.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
MEDCO HEALTH SOLUTIONS, INC. via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Implementation of Public Law No. 111-148, issues related to the Federal Employee Health Benefits Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Issues related to Medicare/Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Prescription Drug User Fee Act (PDUFA).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
SCHILTZ FOODS, INC. via DLA PIPER LLP (US)
2012 · first_quarter · Q1
FY2011 and FY2012 appropriations, provisions on anti-viral therapeutic countermeasures.
Anti-viral therapeutic countermeasures.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2011 · fourth_quarter · RR
Health care financing.
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Implementation of Public Law No. 111-148.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Prescription Drug User Fee Act (PDUFA).
Issues related to Medicare/Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
MEDCO HEALTH SOLUTIONS, INC. via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Implementation of Public Law No. 111-148.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Issues related to Medicare and Medicaid drug rebates.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act.
FY 2012 Budget Resolution: diabetes-related issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
SCHILTZ FOODS, INC. via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
FY2011 and FY2012 appropriations, provisions on anti-viral therapeutic countermeasures.
Anti-viral therapeutic countermeasures.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DES MOINES UNIVERSITY via DLA PIPER LLP (US)
2011 · fourth_quarter · 4T
Implementation of the Patient Protection and Affordable Health Care Act; funding for AHEC; workforce issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDCO HEALTH SOLUTIONS, INC. via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2011 · third_quarter · Q3
S. 965, Family Act of 2011.
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Issues related to Medicare/Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Prescription Drug User Fee Act (PDUFA).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Implementation of Public Law No. 111-148.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Implementation of Public Law No. 111-148.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Issues related to Medicare and Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCHILTZ FOODS, INC. via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Anti-viral therapeutic countermeasures.
FY2011 and FY2012 appropriations, provisions on anti-viral therapeutic countermeasures.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
DES MOINES UNIVERSITY via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Implementation of the Patient Protection and Affordable Health Care Act; funding for AHEC; workforce issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Issues related to Medicare and Medicaid drug rebates.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Issues related to Medicare/Medicaid reimbursements.
S. 965, Family Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Implementation of Public Law No. 111-148.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDCO HEALTH SOLUTIONS, INC. via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Implementation of Public Law No. 111-148.
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
SCHILTZ FOODS, INC. via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Anti-viral therapeutic countermeasures.
FY2010, FY2011 and FY2012 appropriations, provisions on anti-viral therapeutic countermeasures.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
DES MOINES UNIVERSITY via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Implementation of the Affordable Health Care Act; funding for AHEC; workforce issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Issues related to Medicare and Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Issues related to Medicare/Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Prescription Drug User Fee Act (PDUFA).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
MEDCO HEALTH SOLUTIONS, INC. via DLA PIPER LLP (US)
2011 · second_quarter · RR
Issues related to Medicare/Medicaid reimbursements.
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2011 · second_quarter · RR
Implementation of Public Law No. 111-148
FY 2012 Budget Resolution: diabetes-related issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE